FDA Floats Rules For Abuse-Deterrent Generic Opioids
The U.S. Food and Drug Administration on Thursday proposed new research requirements for generic drug makers developing opioid medications that are harder to abuse, the latest move in the agency's avowed...To view the full article, register now.
Already a subscriber? Click here to view full article